IBJNews

Regenstrief taps Deloitte to pick up more health care industry clients

Back to TopCommentsE-mailPrintBookmark and Share

With federal health research funding in decline, Indianapolis-based Regenstrief Institute Inc. wants to make up the difference by serving private health care customers.

The not-for-profit thinks a new partnership with consulting firm Deloitte should bring in more contracts from pharmaceutical companies, medical device makers, health insurers and hospital systems.

Regenstrief has joined a health care and life sciences analytics consortium run by Deloitte called ConvergeHEALTH. Because Deloitte talks to health care and life sciences companies every day, the relationship could bring in more contracts from those companies.

Deloitte also offers data visualization tools that could help Regenstrief and its clients sift through mountains of medical data faster to get to answers they need. Regenstrief maintains massive databases of patient medical records from hospitals and doctors around Indiana and then pays professors at the Indiana University School of Medicine to conduct research projects using those records.

“The quicker you can kind of drill down into the questions that are central to patients and providers and health care systems, the better,” said Mick Murray, a pharmacist who is executive director of the Regenstrief Center for Healthcare Effectiveness Research. “It’s just like in the newspaper; you want to look at the picture and it helps you grasp what’s going on in the text a little bit better.”

Dr. Bill Tierney, Regenstrief’s CEO, expects about two-thirds of the work that comes through the Deloitte partnership to be from drug companies, with the rest split among medical device makers, insurers and health systems.

Such private-sector funding currently makes up about 10 percent to 15 percent of the $30 million in outside funding Regenstrief brings in each year. That percentage could rise to 25 percent to 30 percent if the Deloitte relationship is successful, Tierney said.

But he expects that work to mostly offset declining federal funding.

So far in fiscal year 2014, the National Institutes of Health has handed out $13.2 billion in awards to researchers around the country, which lags far behind the $22.5 billion it gave out in 2013. Congressional funding for the NIH has not kept pace with inflation over the past decade.

Tierney noted that Regenstrief's success rate has held steady in recent years—about 50 percent of its NIH funding requests are granted, compared with a national average of less than 10 percent.

But Tierney wants to avoid having the more than 50 primary researchers and numerous other scientists who work for Regenstrief sit idle. Since drug, device and insurance companies all want to know how various treatments play out among patients once they’re on the market—yet none of those entities have access to actual medical records of patients or the doctors treating the patients—Tierney thinks Regenstrief can help them get the information.

“I know that there is a lot of untapped need out there to be able to do the things we could do,” he said.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
thisissue1-092914.jpg 092914

Subscribe to IBJ
  1. Cramer agrees...says don't buy it and sell it if you own it! Their "pay to play" cost is this issue. As long as they charge customers, they never will attain the critical mass needed to be a successful on company...Jim Cramer quote.

  2. My responses to some of the comments would include the following: 1. Our offer which included the forgiveness of debt (this is an immediate forgiveness and is not "spread over many years")represents debt that due to a reduction of interest rates in the economy arguably represents consideration together with the cash component of our offer that exceeds the $2.1 million apparently offered by another party. 2. The previous $2.1 million cash offer that was turned down by the CRC would have netted the CRC substantially less than $2.1 million. As a result even in hindsight the CRC was wise in turning down that offer. 3. With regard to "concerned Carmelite's" discussion of the previous financing Pedcor gave up $16.5 million in City debt in addition to the conveyance of the garage (appraised at $13 million)in exchange for the $22.5 million cash and debt obligations. The local media never discussed the $16.5 million in debt that we gave up which would show that we gave $29.5 million in value for the $23.5 million. 4.Pedcor would have been much happier if Brian was still operating his Deli and only made this offer as we believe that we can redevelop the building into something that will be better for the City and City Center where both Pedcor the citizens of Carmel have a large investment. Bruce Cordingley, President, Pedcor

  3. I've been looking for news on Corner Bakery, too, but there doesn't seem to be any info out there. I prefer them over Panera and Paradise so can't wait to see where they'll be!

  4. WGN actually is two channels: 1. WGN Chicago, seen only in Chicago (and parts of Canada) - this station is one of the flagship CW affiliates. 2. WGN America - a nationwide cable channel that doesn't carry any CW programming, and doesn't have local affiliates. (In addition, as WGN is owned by Tribune, just like WTTV, WTTK, and WXIN, I can't imagine they would do anything to help WISH.) In Indianapolis, CW programming is already seen on WTTV 4 and WTTK 29, and when CBS takes over those stations' main channels, the CW will move to a sub channel, such as 4.2 or 4.3 and 29.2 or 29.3. TBS is only a cable channel these days and does not affiliate with local stations. WISH could move the MyNetwork affiliation from WNDY 23 to WISH 8, but I am beginning to think they may prefer to put together their own lineup of syndicated programming instead. While much of it would be "reruns" from broadcast or cable, that's pretty much what the MyNetwork does these days anyway. So since WISH has the choice, they may want to customize their lineup by choosing programs that they feel will garner better ratings in this market.

  5. The Pedcor debt is from the CRC paying ~$23M for the Pedcor's parking garage at City Center that is apprased at $13M. Why did we pay over the top money for a private businesses parking? What did we get out of it? Pedcor got free parking for their apartment and business tenants. Pedcor now gets another building for free that taxpayers have ~$3M tied up in. This is NOT a win win for taxpayers. It is just a win for Pedcor who contributes heavily to the Friends of Jim Brainard. The campaign reports are on the Hamilton County website. http://www2.hamiltoncounty.in.gov/publicdocs/Campaign%20Finance%20Images/defaultfiles.asp?ARG1=Campaign Finance Images&ARG2=/Brainard, Jim

ADVERTISEMENT